Qpharm Health Care Profile
Key Indicators
- Authorised Capital ₹ 3.30 M
as on 08-07-2024
- Paid Up Capital ₹ 3.30 M
as on 08-07-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 M
as on 08-07-2024
- Revenue 56.32%
(FY 2023)
- Profit 134.15%
(FY 2023)
- Ebitda 305.60%
(FY 2023)
- Net Worth 65.70%
(FY 2023)
- Total Assets 40.37%
(FY 2023)
About Qpharm Health Care
The Corporate was formerly known as Pill Biosciences India Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.30 M and a paid-up capital of Rs 3.30 M.
The company currently has active open charges totaling ₹1.50 M.
Uma Sharma, Mahesh Gupta, Ashish Gupta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33119RJ2010PLC032691
- Company No.
032691
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Qpharm Health Care?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uma Sharma  | Director | 16-Dec-2020 | Current |
| Mahesh Gupta | Director | 27-Aug-2010 | Current |
| Ashish Gupta | Director | 27-Aug-2010 | Current |
| Anil Agarwal | Director | 02-Sep-2020 | Current |
| Ravi Agarwal | Director | 29-Aug-2020 | Current |
Financial Performance and Corporate Structure Insights of Qpharm Health Care.
Qpharm Health Care Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 56.32% increase. The company also saw a substantial improvement in profitability, with a 134.15% increase in profit. The company's net worth Soared by an impressive increase of 65.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Qpharm Health Care?
In 2023, Qpharm Health Care had a promoter holding of 56.82% and a public holding of 43.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jan 2021 | ₹1.50 M | Open |
How Many Employees Work at Qpharm Health Care?
Qpharm Health Care has a workforce of 23 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Dec 14, 2020, Qpharm Health Care has raised a total of ₹ 5.6 M, with the most recent deal valued at ₹ 2.8 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
